FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

5th Circuit Backs Solvay False Claims Case Dismissal

[ Price : $8.95]

The 5th Circuit Court of Appeals upholds a Texas federal court ruling granting summary judgment to Solvay Pharmaceuticals in a whi...

Analytical Similarity Statistical Guidance Out

[ Price : $8.95]

FDA releases a draft guidance on statistical approaches to evaluating analytical similarity between biosimilars and their referenc...

Safety Alert Issued on Intercepts Ocaliva

[ Price : $8.95]

An FDA safety alert warns that Intercept Pharmaceuticals liver disease drug Ocaliva (obeticholic acid) is being incorrectly dosed ...

FDA Clears Brainlab Radiosurgery Planning Software

[ Price : $8.95]

FDA clears a Brainlab 510(k) for Elements Spine SRS and Elements Cranial SRS, two software applications that aid in the patient-ta...

Public Citizen Sues FDA to Force Benzocaine Ruling

[ Price : $8.95]

Public Citizen asks the DC federal court to compel FDA to act on the advocacy groups petition asking that benzocaine not be permit...

Lawyer Faults New FDA Approach to 510(k)s

[ Price : $8.95]

Attorney Mark DuVal faults what he sees as FDAs new, less collaborative approach to determining whether a 510(k) is substantially ...

FDA Clears ClaroNav Surgical Navigation Device

[ Price : $8.95]

FDA clears a ClaroNav 510(K) for NaviENT, a computer-assisted surgical navigation system for surgical procedures inside a patients...

FDA Meeting on Antimicrobial Resistance Monitoring

[ Price : $8.95]

Federal Register notice: FDA announces a 10/24-25 public meeting entitled 2017 Scientific Meeting of the National Antimicrobial Re...

Workshop on Pediatric Drug Development for Heart Failure

[ Price : $8.95]

Federal Register notice: FDA announces a 10/27 public workshop entitled FDA-University of Maryland CERSI Drug Development in Pedia...

FDA Panel to Review Intraocular Pressure Drug

[ Price : $8.95]

Federal Register notice: FDAs Dermatologic and Ophthalmic Drugs Advisory Committee meets 10/13 to review intraocular pressure drug...